Showing results (141-150 of 351) with videos related to
Sort By:
Pageof 36
The Lancet. Neurology|January 24, 2026
Genetic causes and modifiers of prion diseasesSimon Mead, Peter Hermann, Tze How Mok, et al.British Medical Bulletin|October 3, 2003
Molecular and clinical classification of human prion diseaseJonathan D F Wadsworth, Andrew F Hill, Jonathan A Beck, et al.Transfusion|February 26, 2010
Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplificationM Howard Tattum, Samantha Jones, Suvankar Pal, et al.Nature|January 5, 2017
Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypesWei Qiang, Wai-Ming Yau, Jun-Xia Lu, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 11, 2008
Alterations in Ca2+-buffering in prion-null mice: association with reduced afterhyperpolarizations in CA1 hippocampal neuronsAndrew D Powell, Emil C Toescu, John Collinge, et al.Neurology|July 13, 2026
Performance of Alzheimer Disease Plasma Biomarkers in Patients With Prion DiseasesThomas Coysh, Rhiannon Laban, Elena Veleva, et al.Science (New York, N.Y.)|November 1, 2003
Depleting neuronal PrP in prion infection prevents disease and reverses spongiosisGiovanna Mallucci, Andrew Dickinson, Jacqueline Linehan, et al.The Lancet. Neurology|March 19, 2022
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programmeSimon Mead, Azadeh Khalili-Shirazi, Caroline Potter, et al.Nature|February 26, 2011
Prion propagation and toxicity in vivo occur in two distinct mechanistic phasesMalin K Sandberg, Huda Al-Doujaily, Bernadette Sharps, et al.Scientific Reports|December 4, 2015
Preclinical detection of infectivity and disease-specific PrP in blood throughout the incubation period of prion diseaseElizabeth B Sawyer, Julie Ann Edgeworth, Claire Thomas, et al.Pageof 36